We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+6.96%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$4.16B
AUM Growth
+$312M
Cap. Flow
+$49.6M
Cap. Flow %
1.19%
Top 10 Hldgs %
18.39%
Holding
702
New
49
Increased
376
Reduced
176
Closed
46

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$26.9M
2
YHOO
Yahoo Inc
YHOO
+$20.9M
3
EMC
EMC CORPORATION
EMC
+$19.1M
4
CBRE icon
CBRE Group
CBRE
+$15.9M
5
INTC icon
Intel
INTC
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 25.52%
2 Financials 12.75%
3 Technology 11.83%
4 Communication Services 9.9%
5 Consumer Staples 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECL icon
351
Ecolab
ECL
$75.6B
$1.91M 0.05%
15,658
+4,211
+37% +$508K
MU icon
352
Micron Technology
MU
$1.04T
$1.88M 0.05%
105,685
+30,631
+41% +$467K
BBWI icon
353
Bath & Body Works
BBWI
$4.01B
$1.87M 0.04%
32,668
+8,803
+37% +$519K
BF.B icon
354
Brown-Forman Class B
BF.B
$12B
$1.86M 0.04%
61,228
+7,172
+13% +$223K
PMC
355
DELISTED
PharMerica Corporation
PMC
$1.85M 0.04%
+66,000
New +$1.69M
EXC icon
356
Exelon
EXC
$48.6B
$1.84M 0.04%
77,713
+15,673
+25% +$394K
NTAP icon
357
NetApp
NTAP
$32.9B
$1.84M 0.04%
51,466
+40,904
+387% +$1.25M
BAX icon
358
Baxter International
BAX
$11.6B
$1.83M 0.04%
38,484
+4,960
+15% +$234K
ZTS icon
359
Zoetis
ZTS
$31.6B
$1.82M 0.04%
35,079
+8,030
+30% +$406K
EPZM
360
DELISTED
Epizyme, Inc
EPZM
$1.81M 0.04%
184,000
CME icon
361
CME Group
CME
$92.2B
$1.81M 0.04%
17,280
+5,230
+43% +$546K
CTSH icon
362
Cognizant
CTSH
$21.5B
$1.81M 0.04%
37,861
+1,286
+4% +$73.2K
SAGE
363
DELISTED
Sage Therapeutics
SAGE
$1.8M 0.04%
39,000
-35,000
-47% -$1.42M
PCAR icon
364
PACCAR
PCAR
$69.6B
$1.79M 0.04%
45,732
+7,746
+20% +$295K
CNC icon
365
Centene
CNC
$31.3B
$1.77M 0.04%
52,808
+40,772
+339% +$1.42M
EFX icon
366
Equifax
EFX
$20.3B
$1.77M 0.04%
13,137
+2,893
+28% +$384K
PGR icon
367
Progressive
PGR
$124B
$1.77M 0.04%
56,138
+6,372
+13% +$207K
AWK icon
368
American Water Works
AWK
$26.3B
$1.76M 0.04%
23,563
-4,871
-17% -$381K
MTD icon
369
Mettler-Toledo International
MTD
$26.8B
$1.76M 0.04%
4,199
+1,464
+54% +$581K
WELL icon
370
Welltower
WELL
$178B
$1.76M 0.04%
23,569
+11,787
+100% +$903K
GPC icon
371
Genuine Parts
GPC
$17.1B
$1.74M 0.04%
17,279
+4,076
+31% +$413K
PTLA
372
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.72M 0.04%
75,900
+11,400
+18% +$268K
K
373
DELISTED
Kellanova
K
$1.72M 0.04%
23,612
+10,792
+84% +$826K
CEMP
374
DELISTED
Cempra, Inc.
CEMP
$1.69M 0.04%
70,000
-39,000
-36% -$840K
NSC icon
375
Norfolk Southern
NSC
$78.8B
$1.69M 0.04%
17,418
+3,722
+27% +$339K

Similar funds

Candriam SCA's Q3 2016 Portfolio in Review

As of Q3 2016, Candriam SCA held 702 positions worth $4.16B, up 8.1% from $3.85B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA's Q3 2016 filing shows 49 new, 376 increased, 176 reduced and 46 closed positions. Its largest new stake was Zions Bancorporation: 362,062 shares worth $11.2M. The largest sale was Procter & Gamble, an estimated $26.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Financials and Technology.

  • Candriam SCA's largest Q3 2016 buy was Zions Bancorporation: 362,062 shares worth $11.2M.
  • Candriam SCA added most to Canadian National Railway in Q3 2016, an estimated $30.2M increase.
  • Candriam SCA's biggest Q3 2016 reduction was Procter & Gamble, cutting an estimated $26.9M.
  • Candriam SCA fully exited EMC CORPORATION in Q3 2016, selling an estimated $19.1M.
  • Candriam SCA's ten largest holdings make up 18% of its $4.16B portfolio in Q3 2016.
  • Candriam SCA opened 49 new positions and closed 46 in Q3 2016.
  • Candriam SCA's portfolio value rose 8.1% quarter-over-quarter to $4.16B.

Based on Candriam SCA's 13F filing for Q3 2016, filed 15 Nov 2016.